Wegovy’s Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk’s Blockbuster Obesity Drug
Novo Nordisk’s competition in the obesity drug market is heating up.
Mindfully Curated
Novo Nordisk’s competition in the obesity drug market is heating up.
These companies are each disrupting a different industry through AI.
Nvidia shares rose past $1,000 before the stock split.
Will 24-hour trading be common before we know it?
Caterpillar might be a cyclical stock but has almost been a four-bagger in just five years.
Costco’s share prices are up more than 600% over the past decade. Is it too expensive to buy?
If you have money to put to work in dividend stocks, consider buying boring old Realty Income and its historically high yield.
The stock’s low valuation today could set up investors for oversized gains in the future.
It only took more than 100 years to finally take second place.
Two rapidly growing companies may become Wall Street’s next stock-split stocks.
Ark Investment Management just updated its financial forecasts for electric vehicle giant Tesla, and even Elon Musk thinks they will be tough to meet.
Adobe proved the doubters wrong.
Surprisingly, Nvidia started enhancing graphics for PC gaming and branched out to innovative new areas to apply its technology.
Shares of the vaccine maker are trading up 230% this year.
Delaying your filing for a higher benefit may not work out the way you expect.
Broadcom announced a 10-for-1 stock split to make shares more accessible to all investors.
The memory specialist is set to release its results later this month, and it could spring a positive surprise.
The innovative semiconductor company is riding a powerful tailwind.
The S&P 500 has notched more than two dozen record highs this year, and history warns that investors could miss out on more gains if they avoid the stock market.
The S&P 500 might not be as diversified as you would want from an ETF.